NCT00985361

Brief Summary

The purpose of this study is to determine if daily supplementation with 2000 International Units of Vitamin D will improve hemoglobin A1c in uncontrolled type 2 diabetics.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for not_applicable type-2-diabetes-mellitus

Timeline
Completed

Started Oct 2009

Shorter than P25 for not_applicable type-2-diabetes-mellitus

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 25, 2009

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 28, 2009

Completed
3 days until next milestone

Study Start

First participant enrolled

October 1, 2009

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2010

Completed
Last Updated

May 6, 2010

Status Verified

October 1, 2009

Enrollment Period

5 months

First QC Date

September 25, 2009

Last Update Submit

May 5, 2010

Conditions

Outcome Measures

Primary Outcomes (1)

  • Hemoglobin A1c

    3 months

Study Arms (2)

Vitamin D 2000 international units daily

EXPERIMENTAL
Dietary Supplement: Vitamin D3 2000 international units daily

Vitamin C 500mg daily

ACTIVE COMPARATOR
Dietary Supplement: Vitamin C 500mg daily

Interventions

Vitamin D3 2000 international unit tablets once daily for 3 months

Vitamin D 2000 international units daily
Vitamin C 500mg dailyDIETARY_SUPPLEMENT

Vitamin C 500mg tablets once daily for 3 months

Vitamin C 500mg daily

Eligibility Criteria

Age21 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Type 2 diabetes mellitus
  • Hemoglobin A1c \>7% measured in the 3 months prior to randomization
  • Age 21 to 75 years

You may not qualify if:

  • Renal insufficiency (defined as CrCl \<30mL/min)
  • Gestational diabetes
  • Malabsorption syndrome
  • Patients taking vitamin D supplements at doses \>400 international units daily

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Flower Hospital Family Medicine Residency

Sylvania, Ohio, 43560, United States

Location

Center for Health Services

Toledo, Ohio, 43606, United States

Location

Toledo Hospital Family Medicine Residency

Toledo, Ohio, 43606, United States

Location

Related Publications (1)

  • Soric MM, Renner ET, Smith SR. Effect of daily vitamin D supplementation on HbA1c in patients with uncontrolled type 2 diabetes mellitus: a pilot study. J Diabetes. 2012 Mar;4(1):104-5. doi: 10.1111/j.1753-0407.2011.00164.x. No abstract available.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Ascorbic Acid

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Sugar AcidsAcids, AcyclicCarboxylic AcidsOrganic ChemicalsHydroxy AcidsCarbohydrates

Study Officials

  • Mate M Soric, PharmD

    ProMedica Health System

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 25, 2009

First Posted

September 28, 2009

Study Start

October 1, 2009

Primary Completion

March 1, 2010

Study Completion

March 1, 2010

Last Updated

May 6, 2010

Record last verified: 2009-10

Locations